Compare COO & XHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | XHR |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 1.4B |
| IPO Year | N/A | N/A |
| Metric | COO | XHR |
|---|---|---|
| Price | $82.90 | $15.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $89.64 | $14.14 |
| AVG Volume (30 Days) | ★ 1.9M | 746.7K |
| Earning Date | 03-05-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 3.62% |
| EPS Growth | N/A | ★ 139.32 |
| EPS | ★ 1.87 | 0.55 |
| Revenue | ★ $4,092,400,000.00 | $1,074,772,000.00 |
| Revenue This Year | $6.61 | $4.81 |
| Revenue Next Year | $5.36 | $3.40 |
| P/E Ratio | $43.69 | ★ $27.93 |
| Revenue Growth | ★ 5.06 | 4.29 |
| 52 Week Low | $61.78 | $8.55 |
| 52 Week High | $94.17 | $16.23 |
| Indicator | COO | XHR |
|---|---|---|
| Relative Strength Index (RSI) | 56.75 | 54.49 |
| Support Level | $80.51 | $15.28 |
| Resistance Level | $83.20 | $16.23 |
| Average True Range (ATR) | 1.83 | 0.41 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 97.64 | 50.72 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The firm's customer groups include transient business, group business, and contract business.